-
Our Company
-
iTAb Platform
-
iTAb Pipeline
-
New Drug Discovery
-
News
-
Career
-
Contact
Our Company |
iTAb Platform |
iTAb Pipeline |
New Drug Discovery |
News |
Career |
Contact |
| Science | Efficiency | Quality | Passion |
2023-6-5 |
ITabMed announces the IND approval from NMPA for A-337, a CD3-activating bi-specific antibody targeting EpCAM to treat solid tumors |
2021-12-1 |
ITabMed Completes Series A-round Financing after Spin-off |